Antihistamine OTC Switch: FDA Asking If Rx Products Have "Unique" Aspects

FDA regards the safety profiles of Rx antihistamines Claritin, Allegra and Zyrtec to be at least as good as currently marketed OTC antihistamines, briefing documents for the upcoming May 11 advisory committee meeting indicate.

More from Archive

More from Pink Sheet